©2024 Stanford Medicine
Quantitative 13N-Ammonia Cardiac Rest/Stress Digital PET/CT
Not Recruiting
Trial ID: NCT03170817
Purpose
Accurate measurements from a non-invasive test like myocardial perfusion positron emission
tomography/ computed tomography (PET/CT) may decrease the need for invasive procedures such
as cardiac catheterization.The investigators wish to see if the measurements from cardiac
catheterization can be predicted using a non-invasive 13N-NH3 digital PET/CT scan.
Official Title
Quantitative Rest/Stress Cardiac Perfusion Digital PET/CT: Comparison Between Noninvasive Imaging and Invasive Coronary Angiography.
Stanford Investigator(s)
Guido A. Davidzon
Clinical Associate Professor, Radiology - Rad/Nuclear Medicine
Kip E. Guja, MD PhD
Clinical Instructor, Radiology - Rad/Nuclear Medicine
Andrei Iagaru
Professor of Radiology (Nuclear Medicine)
Eligibility
Inclusion Criteria:
- Patient is ≥ 18 years old at the time of the scan
- Patient has known or suspected coronary artery disease
- Patient has had a recent or will be scheduled for a diagnostic coronary angiogram
- Patient provides written informed consent
- Patient is referred for myocardial perfusion scan
- Patient is capable of complying with study procedures
- Patient is able to remain still for duration of imaging procedure (approximately 60
minutes total for both PET/CT)
Exclusion Criteria:
- Patients who are pregnant or breast feeding
- Patients with contraindications to regadenoson
Intervention(s):
diagnostic test: Cardiac Perfusion Rest/Stress Digital PET/CT
drug: N-13 ammonia
drug: Regadenoson
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Jordan Ciscernos
650-725-6409